← TrialMatch
HomeTrials

The REMINDER4Care Program for Older Adults Supported by Residential and Daycare Facilities

Dementia incidence is rising, posing a public health challenge, but 45% of cases can be prevented by addressing modifiable risk factors. Multidomain trials show that lifestyle changes can improve cognitive function and reduce dementia risk (like the FINGER trial). The REMINDER program, a Portuguese-based dementia risk

Condition(s)Dementia Risk Factors, Prevention, Cognitive Health
StatusRecruiting
PhaseNA
Study typeInterventional
SummaryDementia incidence is rising, posing a public health challenge, but 45% of cases can be prevented by addressing modifiable risk factors. Multidomain trials show that lifestyle changes can improve cognitive function and reduce dementia risk (like the FINGER trial). The REMINDER program, a Portuguese-based dementia risk reduction protocol, was developed for community-dwelling older adults aged 55 and above. However, older adults in Residential and Daycare Facilities (RDF) have distinct needs that demand program adaptation to ensure its relevance and effectiveness. In addition, more studies are needed to evaluate the impact of multidomain interventions with older adults in RDF. To address these challenges, the REMINDER4Care program was developed as a tailored, multidomain intervention to redu
Who can participateInclusion Criteria: * Aged 65 years and older * RDF users * Elementary reading and writing skills Exclusion Criteria: * Have a clinical diagnosis of dementia and/or Mini-Mental State Examination (MMSE) scores below the cutoff for the presence of dementia (MMSE \< 22-27, depending on education level) * Have a psychiatric or neurological condition that impairs cognition in the long term * Have sensory and functional deficits that compromise their participation in the neuropsychological assessment and throughout the intervention sessions
Ages65 Years
SexAll
Accepts healthy volunteersYes
Lead sponsorUniversity of Coimbra
LocationsCoimbra, Portugal, Portugal
Start date2025-05-01
NCT IDNCT06922071
Official listinghttps://clinicaltrials.gov/study/NCT06922071

🔍 Search all trials →